Checkpoint Therapeutics, Inc. is a clinical-stage company specializing in immunotherapy and oncology treatments for solid tumor cancers. Their lead products include Cosibelimab and CK-302, with ongoing clinical trials for various cancers.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay